News

The prestigious award recognises Professor Chris Goodnow's innovative work on immune tolerance and chronic disease.Professor ...
Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...
While most people can use LED light therapy safely, Dr Tandon warns that those on light-sensitive medications or with ...
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis. Phase II studies have shown promising results, although long-term data are ...
AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...
One of the most significant immune changes during menopause is an increase in pro-inflammatory cytokines, such as TNF-α and ...
By focusing on twins and patients with lupus and Parkinson’s disease, a Mexican consortium is generating critical data to ...
AbbVie is acquiring Capstan Therapeutics for up to $2.1 billion, marking a bold step into in vivo CAR-T innovation. Unlike ...
The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...
Discover how butterfly rashes, purple spots, and other skin changes can reveal lupus, blood disorders, and serious diseases ...
Biopharma company AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, giving it access to promising new cell therapies that could treat autoimmune diseases like lupus.
Turmeric and ginger are antioxidant powerhouses—but which is stronger? Discover benefits, side effects, and whether you can ...